Cancer risk in association with Parkinson disease: a population-based study.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2009.11.005PMID 19945903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parkinson's disease, levodopa-use and the risk of melanoma.

  2009cited by this paper
• Dopamine agonists and the risk of cardiac-valve regurgitation.

  2007cited by this paper
• Prospective case–control study of nonfatal cancer preceding the diagnosis of parkinson’s disease

  2007cited by this paper
• A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease

  2007cited by this paper
• Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

  2006cited by this paper
• Malignant Melanoma and Other Types of Cancer Preceding Parkinson Disease

  2006cited by this paper
• Tumours and tremors: how PTEN regulation underlies both

  2006cited by this paper
• Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.

  2006cited by this paper
• Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature

  2006cited by this paper
• Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study

  2005cited by this paper
• The General Practice Research Database

  2004cited by this paper
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

  2004cited by this paper
• Parkinson's--Divergent Causes, Convergent Mechanisms

  2004cited by this paper
• Smoking and Parkinson's disease: Systematic review of prospective studies

  2004cited by this paper
• A prospective study of alcoholism and the risk of Parkinson’s disease

  2004cited by this paper
• The role of oxidative stress in carcinogenesis.

  2004cited by this paper
• Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

  2003cited by this paper
• Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27

  2003cited by this paper
• Validity of the General Practice Research Database

  2003cited by this paper
• Tobacco use and cancer causation: association by tumour type

  2002cited by this paper
• Statin use, hyperlipidaemia, and the risk of breast cancer

  2002cited by this paper
• Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study

  2002cited by this paper
• Mortality and cancer incidence in patients with Parkinson's disease

  2000cited by this paper
• A database worth saving.

  1997cited by this paper
• Calcium-channel blockers and risk of cancer.

  1997cited by this paper
• A database worth saving

  1997cited by this paper
• Occurrence of different cancers in patients with Parkinson's disease

  1995cited by this paper
• Skin colour, MPTP, and Parkinson's disease.

  1987cited by this paper
• Low cancer rates among patients with Parkinson's disease

  1985cited by this paper

• Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner

  2025cites this paper
• Association of Sporadic and Genetic Parkinson’s Disease with Cancer: Insights from the PPMI Cohort

  2025cites this paper
• Linking Parkinson’s disease and melanoma: the impact of copper-driven cuproptosis and related mechanisms

  2025cites this paper
• Impact of Parkinson's disease diagnosis validity on the association with cancer: A systematic review and meta-analysis.

  2025cites this paper
• Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma

  2025cites this paper
• Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence

  2025influential citation
• Association between Parkinson's disease and risk of colorectal cancer: A systematic review and meta‐analysis

  2025cites this paper
• α-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance

  2025cites this paper
• Risk of colorectal cancer in Parkinson’s disease: a systematic review and meta-analysis of 11 million participants

  2025cites this paper
• Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma

  2024cites this paper
• Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies

  2024cites this paper
• Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner

  2024cites this paper
• Identification and validation of a novel Parkinson-Glioma feature gene signature in glioma and Parkinson’s disease

  2024cites this paper
• Synuclein Proteins in Cancer Development and Progression

  2023cites this paper
• Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary

  2023cites this paper
• Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea

  2023cites this paper
• Unravelling the genetic links between Parkinson’s disease and lung cancer

  2023cites this paper
• Parkinson’s disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender

  2022cites this paper
• Understanding the Role of Dopamine in Cancer: Past, Present, and Future.

  2022cites this paper
• Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants

  2021cites this paper
• Rate of hospitalizations and underlying reasons among people with Parkinson’s disease– Population-based cohort study in UK primary care

  2021cites this paper
• Cancer in Parkinson’s Disease, a Review of Literature

  2021cites this paper
• Parkinson’s Disease as a Risk Factor for Melanoma: A Review

  2021cites this paper
• Patients with Parkinson’s disease predict a lower incidence of colorectal cancer

  2021cites this paper
• Cancer risk in Parkinson disease: An updated systematic review and meta‐analysis

  2021influential citation
• Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer

  2021cites this paper
• Linking Parkinson's Disease and Melanoma: Interplay Between α‐Synuclein and Pmel17 Amyloid Formation

  2021cites this paper
• Genetic parkinsonisms and cancer: a systematic review and meta-analysis

  2020cites this paper
• Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis.

  2019cites this paper
• Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective

  2019cites this paper
• Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

  2019cites this paper
• Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword

  2018cites this paper
• What have we learned recently from transgenic mouse models about neurodegeneration? The most promising discoveries of this millennium

  2018cites this paper
• Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms

  2018cites this paper
• Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson's disease model.

  2018cites this paper
• Association between Parkinson's disease and risk of colorectal cancer.

  2017cites this paper
• Metabotropic glutamate receptor 5 mediates the suppressive effect of 6‐OHDA‐induced model of Parkinson's disease on liver cancer

  2017cites this paper
• Association between Parkinson’s disease and risk of prostate cancer in different populations: An updated meta-analysis

  2017cites this paper
• TCF7L2 and CCND1 polymorphisms and its association with colorectal cancer in Mexican patients.

  2016cites this paper
• Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease

  2016influential citation
• Associations between cancer and Parkinson's disease in U.S. elderly adults.

  2016cites this paper
• Associations Between Parkinson Disease and Cancer in US Asian Americans.

  2016cites this paper
• Parkinson's disease and colorectal cancer risk-A nested case control study.

  2016cites this paper
• Risk of lung cancer in Parkinson's disease

  2016cites this paper
• The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53

  2016cites this paper
• Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.

  2016cites this paper
• Cancer in Parkinson's disease.

  2016cites this paper
• The link between Parkinson's disease and breast and prostate cancers: A meta-analysis

  2015cites this paper
• The association between Parkinson’s disease and melanoma: a systematic review and meta-analysis

  2015cites this paper
• Diametrical diseases reflect evolutionary-genetic tradeoffs

  2015cites this paper
• The ultra early diagnosis of Parkinson's disease by the enhanced substantia nigra echo.

  2015cites this paper
• The associations between Parkinson’s disease and cancer: the plot thickens

  2015cites this paper
• Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

  2014cites this paper
• The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: A population‐based prospective study

  2014cites this paper
• p53 in neurodegenerative diseases and brain cancers.

  2014cites this paper
• Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

  2014influential citation
• Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study

  2014cites this paper
• Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

  2013cites this paper
• The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers

  2012cites this paper
• Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update

  2012cites this paper
• Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease

  2012influential citation
• Lack of association between the CC genotype of the rs 7903146 polymorphism in the TCF 7 L 2 gene and rheumatoid arthritis

  2012cites this paper
• Ether-à-go-go 1 (Eag1) Potassium Channel Expression in Dopaminergic Neurons of Basal Ganglia is Modulated by 6-Hydroxydopamine Lesion

  2011cites this paper
• The association between Parkinson's disease and melanoma

  2011cites this paper
• Parkinson Disease and Malignant Melanoma in First-degree Relatives of Patients With Early-onset Melanoma

  2011cites this paper
• Cancer and Parkinson's disease: the odd couple.

  2011cites this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cites this paper
• Meta-analysis of the relationship between Parkinson disease and melanoma

  2011cites this paper
• On the metabolic origin of cancer: substances that target tumor metabolism

  2011cites this paper
• Rare variants analysis of cutaneous malignant melanoma genes Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease in Parkinson's disease

  year unknowncites this paper